Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

PVLA Relative to the S&P 500

Seasonal Chart Analysis

Analysis of the Palvella Therapeutics Inc. (NASD:PVLA) seasonal charts above shows that a Buy Date of June 30 and a Sell Date of September 24 has resulted in a geometric average return of 7.92% above the benchmark rate of the S&P 500 Total Return Index over the past 9 years. This seasonal timeframe has shown positive results compared to the benchmark in 6 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 9 years by an average of 43.43% per year.

A word of caution: Only 9 years of data is available for shares of PVLA, perhaps insufficient to create a seasonal profile that accurately gauges the seasonal tendencies influencing the investment. Ideally, while 20 years is preferred, at least 10 years of data is required to perform a seasonal analysis that is considered to be reliable for future seasonal periods.

Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform. The company was founded in 2015 and is headquartered in Wayne, PA.

To download PVLA seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: PVLA